Enhance EQUITY in Clinical Trials
Image
![Scientist reviewing pictures presented holographically](https://public4.pagefreezer.com:443/content/FDA/25-10-2022T09:17/https://www.fda.gov/files/styles/main_image_medium/public/medical-technology-concept-remote-medicine-electronic-medical-record-picture-id1223789376.jpg?itok=Hoh0LADw)
OMHHE aims to enhance EQUITY in clinical trials by:
- Identifying barriers to clinical trial enrollment for underrepresented populations (including, but not limited to, ethnicity, race, age, disability and geography).
- Improving data collection and data quality for underrepresented populations in clinical trials.
- Employing innovative strategies, trainings, education, and communication methods to increase clinical trial enrollment for underrepresented populations.
- Increasing training for diverse clinical trial investigators and other researchers.